<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "vinorelbine inj VIAL>
<dose><value>25</value>
<value>30</value>
<value>15</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drug><value>vinorelbine inj VIAL</value>
</drug><strength><value>10 mg/mL</value>
</strength><frequency><value>ONCE</value>
</frequency><instruction><value>DAY 1. Administer dose diluted in 50 mL 0.9% sodium chloride over 10 minutes concurrently with prehydration.</value>
<value>DAY 8. Administer dose diluted in 50 mL 0.9% sodium chloride over 10 minutes concurrently with prehydration.</value>
<value>DAY 15. Administer dose diluted in 50 mL 0.9% sodium chloride over 10 minutes concurrently with 0.9% sodium chloride infusion.</value>
<value>DAY 22. Administer dose diluted in 50 mL 0.9% sodium chloride over 10 minutes concurrently with 0.9% sodium chloride infusion.</value>
<value>DAY 1 of 21. Administer dose diluted in 50 mL 0.9% sodium chloride over 10 minutes concurrently with prehydration.</value>
<value>DAY 8 of 21. Administer dose diluted in 50 mL 0.9% sodium chloride over 10 minutes concurrently with 0.9% sodium chloride infusion.</value>
<value>DAY 1 of 21. Administer dose diluted in 50 mL 0.9% sodium chloride over 10 minutes concurrently with 0.9% sodium chloride infusion.</value>
<value>DAY 1 of 21. Administer dose diluted in 50 mL 0.9% sodium chloride over 10 minutes concurrently with saline infusion.</value>
</instruction><volume><value>1 mL</value>
<value>5 mL</value>
</volume><units><value>mg/m2</value>
</units><additionalnotes><value>DAY 1. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC less than 1.5 OR Plts less than 100 x 109/L: Delay one week. If CrCl is greater than or equal to 50 mL/minute, give chemotherapy as ordered. If CrCl less than 50 mL/minute,hold chemotherapy and contact physician. If AST/ALT is less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos is 1.5 to 5 x ULN OR bilirubin is ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos is greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 8. If ANC greater than or equal to 1 AND Plts greater than or equal to 75 x 109/L, Give as ordered. If ANC is greater than 0.5 and less than 1 OR Plts are greater than or equal to 50 and less than 75 x 109/L: Administer 75% of vinorelbine dose. If ANC is less than or equal to 0.5 OR Plts less than 50 x 109/L, HOLD treatment. If CrCl is greater than or equal to 50 mL/minute, give chemotherapy as ordered. If CrCl less than 50 mL/minute, hold chemotherapy and contact physician. If AST/ALT is less than or equal to 1.5 ULN AND Alk Phos is less than 1.5 x ULN AND bilirubin WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin is ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 15. If ANC greater than or equal to 1 AND Plts greater than or equal to 75 x 109/L, Give as ordered. If ANC is greater than 0.5 and less than 1 OR Plts are greater than or equal to 50 and less than 75 x 109/L: Administer 75% of vinorelbine dose. If ANC is less than or equal to 0.5 OR Plts less than 50 x 109/L, HOLD treatment. If AST/ALT is less than or equal to 1.5 x ULN AND Alk Phos is less than 1.5 x ULN AND bilirubin WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin is ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 22. If ANC greater than or equal to 1 AND Plts greater than or equal to 75 x 109/L, Give as ordered. If ANC is greater than 0.5 and less than 1 OR Plts are greater than or equal to 50 and less than 75 x 109/L: Administer 75% of vinorelbine dose. If ANC is less than or equal to 0.5 OR Plts less than 50 x 109/L, HOLD treatment. If AST/ALT is less than or equal to 1.5 x ULN AND Alk Phos is less than 1.5 x ULN AND bilirubin WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin is ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 1. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC less than 1.5 OR Plts less than 100 x 109/L: Delay one week or adjust dose as per prescriber. If CrCl is greater than or equal to 50 mL/minute, give chemotherapy as ordered. If CrCl less than 50 mL/minute, hold chemotherapy and contact physician. If AST/ALT less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 8. If ANC greater than or equal to 1 AND Plts greater than or equal to 75 x 109/L, Give as ordered. If ANC is greater than 0.5 and less than 1 OR Plts are greater than 50 and less than 75 x 109/L: Give 75% of vinorelbine dose. If ANC is less than or equal to 0.5 OR Plts are less than 50 x 109/L: HOLD treatment. If AST/ALT less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 1. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC is greater than or equal to 1 and less than 1.5: Reduce dose to 75%. If ANC is less than 1 OR Plts are less than 100 x 109/L: Delay treatment 1 week. If AST/ALT less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 8. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC is greater than or equal to 1 and less than 1.5: Reduce dose to 75%. If ANC is less than 1 OR Plts are less than 100 x 109/L: Delay treatment 1 week. If AST/ALT less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 1. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC less than 1.5 OR Plts less than 100 x 109/L: Delay one week. If CrCl is greater than or equal to 50 mL/minute, give as ordered. If CrCl less than 50 mL/minute, hold chemotherapy and contact prescriber. If AST/ALT less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos is greater than or equal to 1.5 up to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 1. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC less than 1.5 OR Plts less than 100 x 109/L: Delay one week or dose adjust as per prescriber. If AST/ALT is less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos is greater than or equal to 1.5 up to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 8. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC is greater than 1 and less than 1.5: Give 75% of vinorelbine dose. If ANC is less than or equal to 1 OR Plts are less than 100 x 109/L: HOLD treatment. If AST/ALT less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 1. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC less than 1.5 OR Plts less than 100 x 109/L: Delay one week. If CrCl is greater than or equal to 50 mL/minute, give as ordered. If CrCl less than 50 mL/minute, hold chemotherapy and contact prescriber. If AST/ALT less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 8. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC is greater than or equal to 1 and less than 1.5: Give 75% of vinorelbine dose. If ANC is less than 1 OR Plts are less than 100 x 109/L: Delay 1 week. If AST/ALT less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 1. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC less than 1.5 OR Plts less than 100 x 109/L: Delay one week. If AST/ALT less than or equal to 1.5 x ULN AND Alk Phos is less than 1.5 x ULN AND bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 8. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC is greater than 1 and less than 1.5: Give 75% of vinorelbine dose. If ANC is less than or equal to 1 OR Plts are less than 100 x 109/L: Hold treatment. If AST/ALT less than or equal to 1.5 x ULN and Alk Phos is less than 1.5 x ULN and bilirubin is WLN: Give as ordered. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin is greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
<value>DAY 1. If ANC greater than or equal to 1.5 AND Plts greater than or equal to 100 x 109/L, Give as ordered. If ANC less than 1.5 OR Plts less than 100 x 109/L: Delay one week. If CrCl is greater than or equal to 50 mL/minute, give chemotherapy as ordered. If CrCl less than 50 mL/minute,hold chemotherapy and contact physician. If AST/ALT greater than 1.5 to 5 x ULN AND Alk Phos 1.5 to 5 x ULN OR bilirubin ULN to 1.5 x ULN: Administer 75% of vinorelbine dose. If AST/ALT greater than 5 x ULN AND Alk Phos greater than 5 x ULN OR bilirubin greater than 1.5 x ULN: HOLD treatment. If vinorelbine held for hepatic toxicity, repeat liver function tests weekly. Once recovered, dose vinorelbine at 75%.</value>
</additionalnotes><population><value>Adjuvant Vinorelbine/CISplatin (every 28 days). Non-Small Cell Lung Cancer</value>
<value>Adjuvant Vinorelbine/CISplatin (every 21 days). Non-Small Cell Lung Cancer</value>
<value>Vinorelbine (Day 1 &amp; 8 every 21 Days). Non-Small Cell Lung Cancer (Advanced Stage)</value>
<value>Vinorelbine / CISplatin. Advanced NSCLC</value>
<value>Vinorelbine / CARBOplatin. Non-Small Cell Lung Cancer (Advanced Stage)</value>
<value>CISplatin &amp; Vinorelbine with CONCURRENT RT. Non-Small Cell Lung Cancer</value>
<value>Vinorelbine and CARBOplatin with CONCURRENT RT. Non-Small Cell Lung Cancer.</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value></value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>